1. |
Cummings DE, Flum DR. Gastrointestinal surgery as a treatment for diabetes[J]. JAMA, 2008, 299(3):341-343.
|
2. |
Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity[J]. Ann Surg, 2000, 232(4):515-529.
|
3. |
Cummings DE, Overduin H, Foster-Schubert KE. Gastric bypass for obesity:mechanisms of weight loss and diabetes resolution[J].J Clin Endocrinol Metab, 2004, 89(6):2608-2615.
|
4. |
Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus[J]. Ann Surg, 2003, 238(4):467-484.
|
5. |
Pories WJ. Diabetes:the evolution of a new paradigm[J]. Ann Surg, 2004, 239(1):12-13.
|
6. |
Hickey MS, Pories WJ, MacDonald KG, et al. A new paradigm for type 2 diabetes mellitus:could it be a disease of the foregut?[J]. Ann Surg, 1998, 227(5):637-643.
|
7. |
Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes:a new perspective for an old disease[J]. Ann Surg, 2004, 239(1):1-11.
|
8. |
王瑜, 王燕婷, 王烈. 胃转流术对非肥胖型2型糖尿病的治疗作用[J]. 中国普通外科杂志, 2008, 17(10):1003-1006.
|
9. |
Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes[J]. Ann Surg, 2006, 244(5):741-749.
|
10. |
Araujo AC, Bonfleur ML, Balbo SL, et al. Duodenal-jejunal bypass surgery enhances glucose tolerance and beta-cell function in western diet obese rats[J]. Obes Surg, 2012, 22(5):819-826.
|
11. |
Klein S, Fabbrini E, Patterson BW, et al. Moderate effect of duod-enal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes[J]. Obesity (Silver Spring), 2012, 20(6):1266-1272.
|
12. |
Geloneze B, Geloneze SR, Chaim E, et al. Metabolic surgery fornon-obese type 2 diabetes:incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical cont-rolled study[J]. Ann Surg, 2012, 256(1):72-78.
|
13. |
Portha B, Giroix MH, Tourrel-Cuzin C, et al. The GK rat:a prototype for the study of non-overweight type 2 diabetes[J]. Methods Mol Biol, 2012, 933:125-159.
|
14. |
Kimura K, Toyota T, Kakizaki M, et al. Impaired insulin secretion in the spontaneous diabetes rats[J]. Tohoku J Exp Med, 1982, 137(4):453-539.
|
15. |
de Luis D, Domingo M, Romero A, et al. Effects of duodenal-jejunal exclusion on beta cell function and hormonal regulation in Goto-Kakizaki rats[J]. Am J Surg, 2012, 204(2):242-247.
|
16. |
Bradley D, Conte C, Mittendorfer B, et al. Gastric bypass and banding equally improve insulin sensitivity and β cell function[J].J Clin Invest, 2012, 122(12):4667-4674.
|
17. |
Liu Y, Zhou Y, Wang Y, et al. Roux-en-Y gastric bypass-inducedimprovement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1[J]. Obes Surg, 2011, 21(9):1424-1431.
|
18. |
Zhang X, Huang W, Zhang Y, et al. Effects of Roux-en-Y operations on glucose homeostasis in obese GK rats[J]. Surg Endosc, 2011, 25(11):3493-3498.
|
19. |
Mueller RA, Lundberg DB, Breese GR, et al. The neuropharmacology of respiratory control[J]. Neuropharmacol Rev, 1982, 34(3):255-285.
|
20. |
Vila J. Protection from pentobarbital lethality mediated by pavlovianconditioning[J]. Pharmacol Biochem Behav, 1989, 32(1):365-366.
|
21. |
Han LO, Zhou LH, Cheng SJ, et al. Key details of the duodenal-jejunal bypass in type 2 diabetes mellitus rats[J]. World J Gastr-oenterol, 2011, 17(45):5021-5027.
|
22. |
Flegal MC, Kuhlman SM. Anesthesia monitoring equipment for laboratory animals[J]. Lab Anim (NY), 2004, 33(7):31-36.
|
23. |
Lopez-Vidriero MT, Costello J, Clark TJ, et al. Effect of atropineon sputum production[J]. Thorax, 1975, 30(5):543-547.
|
24. |
Burch JM, Denton JR, Noble RD. Physiologic rationale for abbre-viated laparotomy[J]. Surg Clin North Am, 1997, 77(4):779-782.
|
25. |
Sessler DI. Mild perioperative hypothermia[J]. N Engl J Med, 1997, 336(24):1730-1737.
|